Preparat: Lergigan®, Lergigan® forte, Lergigan® mite, Phenergan, Phénergan, Phenergan 2,5 %, Phenergan Sanofi, Prometazin Actavis, Promethazin-neuraxpharm
ATC kod: R06AD02
Substanser: prometazin, prometazinhydroklorid
Det saknas publicerade studier med kliniskt relevant analys av könsskillnader vad gäller effekt eller säkerhet av prometazin.
The pharmacokinetics of promethazine was evaluated in an open-label study with crossover design. Healthy subjects (18 men, 18 women) were randomized to two 12.5 mg suppositories, one 25 mg suppository, one 50 mg suppository, or 50 mg oral syrup. Promethazine pharmacokinetics was reported to be similar in men and women .
Promethazine and morphine as surgical premedication was evaluated in a double-blind study (96 men, 174 women). Patients were randomized to receive injections with either morphine 5 or 10 mg alone or in combination with promethazine 6.25 mg, 12.5 mg, or 25 mg. Promethazine 25 mg alone was also studied. The sedation level was assessed by a nurse at 15 and 30 minutes after injection and by the patient at 24h after surgery. The authors report that men in the study had lower mean sedation scores than women, however, this effect could be explained by weight as the men were heavier than the women .
The antiemetic efficacy of promethazine was evaluated based on medical records for 369 patients undergoing radiofrequency catheter ablation performed during 4 years. Women had increased risk of nausea. Patients who received larger doses of promethazine had a lower incidence of vomiting .
No studies with a clinically relevant sex analysis regarding adverse effects of promethazine have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
A study of case series of promethazine overdose explored the relationship between possible predictors and delirium. Women and men had similar probability to have delirium (26% vs. 29%) .
Promethazine is a potentially inappropriate medication for use in elderly . In a large American study of 19.5 million emergency department visits, promethazine was among the five most common potentially inappropriate medications used. Female sex was associated with more potentially inappropriate medications than men, odds ratio 1.39 .
Fler kvinnor än män hämtade ut läkemedel innehållande prometazin (ATC-kod R06AD02) på recept i Sverige år 2015, totalt 48 671 kvinnor och 23 039 män. Det motsvarar 9,9 respektive 4,7 personer per tusen invånare. I genomsnitt var läkemedel innehållande prometazin 2,0 gånger vanligare hos kvinnor .
Faktagranskat av: Mia von Euler
Godkänt av: Karin Schenck-Gustafsson